Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
978.7 INR | +3.92% | +11.26% | +50.74% |
May. 23 | Strides Pharma Science Turns to Consolidated Net Profit in Fiscal Q4; Shares Down 3% | MT |
May. 22 | Transcript : Strides Pharma Science Limited, Q4 2024 Earnings Call, May 22, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+50.74% | 1.04B | |
+20.37% | 43.39B | |
+19.44% | 22.01B | |
+17.85% | 15.46B | |
+25.55% | 14.93B | |
+60.99% | 13.13B | |
-0.05% | 6.79B | |
-15.02% | 6.36B | |
-8.87% | 5.73B | |
+10.57% | 5.43B |
- Stock Market
- Equities
- STAR Stock
- News Strides Pharma Science Limited
- Strides Pharma Arm Gets US FDA's Approval for Generic Drug for Hypocalcemia